The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
High prevalence of NSAID enteropathy as shown by a simple faecal test
Open accessAbstract
BACKGROUND: The diagnosis of non-steroidal anti-inflammatory drug (NSAID) induced enteropathy is difficult, requiring enteroscopy or the use of four day faecal excretion of 111 In labelled white cells. AIMS: To assess faecal calprotectin (a non-degraded neutrophil cytosolic protein) as a method for diagnosing NSAID enteropathy. METHODS: Single stool faecal calprotectin concentrations were compared with the four day faecal excretion of 111 In labelled white cells in 47 patients taking NSAIDs. The prevalence and severity of NSAID enteropathy was assessed using this method in 312 patients (192 with rheumatoid arthritis, 65 with osteoarthritis, 55 with other conditions) taking 18 different NSAIDs. RESULTS: The four day faecal excretion of 111 In white cells correlated significantly with faecal calprotectin concentrations. In the group of 312 patients on NSAIDs faecal calprotectin concentrations were significantly higher than in controls, the prevalence of NSAID enteropathy being 44%. The prevalence and severity of NSAID enteropathy was independent of the particular type or dose of NSAID being taken or other patient variables. CONCLUSIONS: Assay of faecal calprotectin provides a simple practical method for diagnosing NSAID enteropathy in man. Forty four per cent of patients receiving these drugs had NSAID induced enteropathy when assessed by this technique; 20% of these had comparable levels of inflammation to that previously reported in patients with inflammatory bowel disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gastrointestinal Damage Associated with the Use of Nonsteroidal Antiinflammatory Drugs
Allison, M. C., Howatson, A. G., Torrance, C. J., Lee, F. D., & Russell, R. I. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209103271101 · Cited by 958
Assessment of the Neutrophil Dominating Protein Calprotectin in Feces: A Methodologic Study
RØseth, A. G., Fagerhol, M. K., Aadland, E., & Schjønsby, H. (1992) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529209011186 · Cited by 669
Self-citationFaecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test.
Löser, C., Möllgaard, A., & Fölsch, U. R. (1996) · Gut · doi:10.1136/gut.39.4.580 · Cited by 554
Røseth, A. G., Aadland, E., Jahnsen, J., & Raknerud, N. (1997) · Digestion · doi:10.1159/000201441 · Cited by 365
Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans
Bjarnason, I., Zanelli, G., Smith, T., Prouse, P., Williams, P., Smethurst, P., Delacey, G., Gumpel, M. J., & Levi, A. J. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90909-7 · Cited by 351
Self-citationLangman, M. J., Morgan, L., & Worrall, A. (1985) · BMJ · doi:10.1136/bmj.290.6465.347 · Cited by 340
Bjarnason, I., So, A., Levi, A. J., Peters, T., Williams, P., Zanelli, G., Gumpel, J. M., & Ansell, B. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92739-9 · Cited by 305
Self-citationBjarnason, I., Williams, P., Smethurst, P., Peters, T. J., & Levi, A. J. (1986) · Gut · doi:10.1136/gut.27.11.1292 · Cited by 267
Self-citationSingh, G., & Ramey, D. R. (1998) · PubMed · Cited by 242
Bjarnason, I., Prouse, P., Smith, T., Gumpel, M., Zanelli, G., Smethurst, P., Levi, S., & Levi, A. J. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91075-0 · Cited by 218
Self-citation
Cited by
Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity
Zhernakova, A., Kurilshikov, A., Bonder, M. J., Tigchelaar, E. F., Schirmer, M., Vatanen, T., Mujagic, Z., Vila, A. V., Falony, G., Vieira-Silva, S., et al. (2016) · Science · doi:10.1126/science.aad3369 · Cited by 1,914
Laboratory markers in IBD: useful, magic, or unnecessary toys?
Vermeire, S., Van Assche, G., & Rutgeerts, P. (2006) · Gut · doi:10.1136/gut.2005.069476 · Cited by 952
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease
DʼHaens, G., Ferrante, M., Vermeire, S., Baert, F., Noman, M., Moortgat, L., Geens, P., Iwens, D., Aerden, I., Van Assche, G., et al. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22917 · Cited by 816
Tibble, J. A., Sigthorsson, G., Bridger, S., Fagerhol, M. K., & Bjarnason, I. (2000) · Gastroenterology · doi:10.1053/gast.2000.8523 · Cited by 759
Self-citationvan Rheenen, P. F., Van de Vijver, E., & Fidler, V. (2010) · BMJ · doi:10.1136/bmj.c3369 · Cited by 714
Diclofenac: an update on its mechanism of action and safety profile
Gan, T. J. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.486301 · Cited by 600
Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs
Bjarnason, I., Scarpignato, C., Holmgren, E., Olszewski, M., Rainsford, K. D., & Lanas, A. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.10.049 · Cited by 530
Self-citationCalprotectin: from biomarker to biological function
Jukic, A., Bakiri, L., Wagner, E. F., Tilg, H., & Adolph, T. E. (2021) · Gut · doi:10.1136/gutjnl-2021-324855 · Cited by 500
A Quantitative Analysis of NSAID-Induced Small Bowel Pathology by Capsule Enteroscopy
Maiden, L., Thjodleifsson, B., Theodors, A., Gonzalez, J., & Bjarnason, I. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.020 · Cited by 499
Self-citationSipponen, T., Savilahti, E., Kolho, K.-L., Nuutinen, H., Turunen, U., & Färkkilä, M. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20312 · Cited by 480
Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease
Konikoff, M. R., & Denson, L. A. (2006) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200606000-00013 · Cited by 453
Tibble, J. A., Sigthorsson, G., Foster, R., Forgacs, I., & Bjarnason, I. (2002) · Gastroenterology · doi:10.1053/gast.2002.34755 · Cited by 441
Self-citationFrom symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation
Sands, B. E. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.02.072 · Cited by 373
Exercise-Induced Splanchnic Hypoperfusion Results in Gut Dysfunction in Healthy Men
van Wijck, K., Lenaerts, K., van Loon, L. J. C., Peters, W. H. M., Buurman, W. A., & Dejong, C. H. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022366 · Cited by 359
“The latter is considered a strong indicator of intestinal inflammation in specific, and has been found to correlate to other parameters of intestinal inflammation in inflammatory bowel disease [46] and enteropathy induced by non-steroidal anti-inflammatory drugs (NSAID) [47].”
BackgroundArasaradnam, R. P., Brown, S., Forbes, A., Fox, M. R., Hungin, P., Kelman, L., Major, G., O’Connor, M., Sanders, D. S., Sinha, R., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315909 · Cited by 332
Schoepfer, A. M., Beglinger, C., Straumann, A., Trummler, M., Renzulli, P., & Seibold, F. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20986 · Cited by 326
Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation
Foell, D., Frosch, M., Sorg, C., & Roth, J. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.02.023 · Cited by 314
Present status and strategy of NSAIDs-induced small bowel injury
Higuchi, K., Umegaki, E., Watanabe, T., Yoda, Y., Morita, E., Murano, M., Tokioka, S., & Arakawa, T. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-009-0102-2 · Cited by 292
The influence of a short-term gluten-free diet on the human gut microbiome
Bonder, M. J., Tigchelaar, E. F., Cai, X., Trynka, G., Cenit, M. C., Hrdlickova, B., Zhong, H., Vatanen, T., Gevers, D., Wijmenga, C., et al. (2016) · Genome Medicine · doi:10.1186/s13073-016-0295-y · Cited by 286
Waugh, N., Cummins, E., Royle, P., Kandala, N.-B., Shyangdan, D., Arasaradnam, R., Clar, C., & Johnston, R. (2013) · Health Technology Assessment · doi:10.3310/hta17550 · Cited by 286
PLAYFORD, R. J., MACDONALD, C. E., CALNAN, D. P., FLOYD, D. N., PODAS, T., JOHNSON, W., WICKS, A. C., BASHIR, O., & MARCHBANK, T. (2001) · Clinical Science · doi:10.1042/cs1000627 · Cited by 141
Metadata
- Authors
- Tibble, J. A., Sigthorsson, G., Foster, R., Scott, D., Fagerhol, M. K., Roseth, A., & Bjarnason, I.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 1999-09-01
- Volume
- 45
- Issue
- 3
- Pages
- 362-366
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2125677376
- Cited by
- 307
- References
- 27
- FWCI
- 5.25
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.